Historical record - last NADAC effective date: 4/20/2022
Product Information
OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1796 per EA under NDC 31722019405. Its NADAC has been published 245 times since Aug 16, 2017.
FDA first approved this application on Mar 22, 2017. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Oxycodone and Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
325; 10 mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722019405
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/20/2022
Active Ingredients
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207419FDA Approved
3/22/2017
TE Code
AA
On Market Since
4/11/2017
Pharmacological Classes
Price Statistics
The NADAC for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET has been published 245 times since Aug 16, 2017, and over the history we have for it it has declined 58.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1796 per EA |
|---|---|
| All-time high | $0.4616 (Sep 13, 2017) |
| All-time low | $0.1580 (Sep 22, 2021) |
| Median price | $0.2563 |
| Average price | $0.2610 |
| Largest weekly change | +21.9% (May 22, 2019) |
| Weeks tracked | 245 |
| Tracking since | Aug 16, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+1.0%
All
-58.0%
Last surveyed Apr 20, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.1796 per EA (NDC 31722019405), effective Apr 20, 2022.
How has the price of OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET has declined 58.0%. It has been tracked across 245 weekly CMS publications since Aug 16, 2017.
What are the highest and lowest recorded NADAC prices for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
Since Aug 16, 2017, the NADAC for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET has ranged from a low of $0.1580 (Sep 22, 2021) to a high of $0.4616 (Sep 13, 2017), with a median of $0.2563 per EA.
Are there cheaper alternatives to OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?
OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET (NDC 31722019405) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.